[144] ESAB Corp SEC Filing

Rhea-AI Filing Summary

ESAB Corp insider filing reports a proposed sale of 1,060 common shares through Fidelity Brokerage Services LLC on 10/03/2025 with an aggregate market value of $125,080.00 and the shares trade on the NYSE. The filing shows those shares were acquired by restricted stock vesting from the issuer on 01/10/2025 (511 shares), 03/08/2025 (331 shares) and earlier on 02/22/2018 (218 shares), and payment was for compensation. The filer also disclosed a prior sale in the past three months: 2,369 common shares sold on 08/22/2025 for gross proceeds of $277,466.45. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• 1,060 shares proposed for sale are explicitly disclosed with $125,080.00 aggregate market value
• All acquired shares shown were from restricted stock vesting and paid as compensation, clearly documented

Negative

• A prior insider sale of 2,369 shares on 08/22/2025 produced $277,466.45, indicating recent insider liquidity
• Filing lacks ownership percentage and post-sale holdings so investor impact is unclear

Insights

Insider Transactions Analyst

TL;DR: Insider plans to sell 1,060 shares worth $125,080; prior sale of 2,369 shares produced $277,466.45.

The filing documents a proposed Rule 144 sale of 1,060 common shares scheduled for 10/03/2025, executed through Fidelity Brokerage Services LLC on the NYSE. The shares were acquired primarily via restricted stock vesting and were paid as compensation, which is explicitly stated.

The disclosure of a recent sale of 2,369 shares on 08/22/2025 for $277,466.45 is material for monitoring insider liquidity but no additional context (e.g., ownership percentage) is provided in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1060	125080.00	60698710	10/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2025	Restricted Stock Vesting	Issuer			511	01/10/2025	Compensation
Common	02/22/2018	Restricted Stock Vesting	Issuer			218	02/22/2018	Compensation
Common	03/08/2025	Restricted Stock Vesting	Issuer			331	03/08/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vusumuzi A. Mlingo 909 Rose Avenue, 8th Floor North Bethesda MD 20852	Common	08/22/2025	2369	277466.45

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ESAB (ESAB) Form 144 disclose?

The Form 144 discloses a proposed sale of 1,060 common shares on 10/03/2025 via Fidelity with an aggregate market value of $125,080.00.

How were the shares being sold acquired?

The filing states the shares were acquired by restricted stock vesting on 01/10/2025, 02/22/2018, and 03/08/2025, and paid as compensation.

Did the filer sell any ESAB shares recently?

Yes. The filer sold 2,369 common shares on 08/22/2025 for gross proceeds of $277,466.45, as disclosed in the filing.

Where will the proposed sale be executed?

The proposed sale is to be executed on the NYSE through Fidelity Brokerage Services LLC.

Does the filing state any undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.